Profil
John Mellors is the founder of Infectious Disease Connect, Inc.
Postes actifs de John Mellors
| Sociétés | Poste | Début |
|---|---|---|
Abound Bio, Inc.
 Abound Bio, Inc. BiotechnologyHealth Technology Part of Galapagos NV, Abound Bio, Inc. is a biotechnology company based in Pittsburgh, PA. The company's mission is to generate novel antibody-based biological therapeutics to meet unmet medical needs in the fields of cancer and infectious diseases. Abound Bio's industry-leading human antibody libraries offer size, diversity, and developability advantages that incorporate different binder formats into appropriate therapeutic platforms. The company was founded by Dimiter Dimitrov and John Mellors, with John Mellors serving as CEO since incorporation. Abound Bio was acquired by Galapagos NV on June 21, 2022 for $14 million. | Directeur Général | - |
Anciens postes connus de John Mellors
| Sociétés | Poste | Fin |
|---|---|---|
Infectious Disease Connect, Inc.
 Infectious Disease Connect, Inc. Specialty TelecommunicationsCommunications Infectious Disease Connect, Inc. engages in the provision of telemedicine services to hospitals. It offers IL?M Insight which provides virtual stewardship and tele-infection prevention and control. The company was founded by Rima Abdel-Massih and John Mellors in 2013 and is headquartered in Pittsburgh, PA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Infectious Disease Connect, Inc.
Infectious Disease Connect, Inc. Specialty TelecommunicationsCommunications Infectious Disease Connect, Inc. engages in the provision of telemedicine services to hospitals. It offers IL?M Insight which provides virtual stewardship and tele-infection prevention and control. The company was founded by Rima Abdel-Massih and John Mellors in 2013 and is headquartered in Pittsburgh, PA. | Communications |
Abound Bio, Inc.
Abound Bio, Inc. BiotechnologyHealth Technology Part of Galapagos NV, Abound Bio, Inc. is a biotechnology company based in Pittsburgh, PA. The company's mission is to generate novel antibody-based biological therapeutics to meet unmet medical needs in the fields of cancer and infectious diseases. Abound Bio's industry-leading human antibody libraries offer size, diversity, and developability advantages that incorporate different binder formats into appropriate therapeutic platforms. The company was founded by Dimiter Dimitrov and John Mellors, with John Mellors serving as CEO since incorporation. Abound Bio was acquired by Galapagos NV on June 21, 2022 for $14 million. | Health Technology |
